Pharmaxis Announces First Sales of Aridol® in USA
13th
Dec 18
Release Date: 13/12/2018 8:30am
Pharmaceutical research company Pharmaxis (ASX: PXS) today announced the first sales of its asthma diagnostic Aridol® (mannitol bronchial challenge test) in the United States following the relaunch of the product.
Categories: News and Media